Cervical intraepithelial neoplasia grade 3 lesions can regress

APMIS

Volumn 115, Issue 12, 2007, Pages 1409-1414

  Munk, Ane Cecilie ^a   Kruse, Arnold Jan ^a,d   Van Diermen, Bianca ^a   Janssen, Emiel A M ^a   Skaland, Ivar ^a   Gudlaugsson, Einar ^a   Nilsen, Stein Tore ^a,b   Baak, Jan P A ^a,b,c  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cervix; HSIL; Intraepithelial neoplasia; Regression

Indexed keywords

ARTICLE; BONE BIOPSY; CANCER GRADING; CANCER PATIENT; CANCER REGRESSION; CANCER SIZE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PUNCH BIOPSY; UTERINE CERVIX CARCINOMA IN SITU;

BIOPSY; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; NEOPLASM REGRESSION, SPONTANEOUS; TIME; UTERINE CERVICAL NEOPLASMS;

EID: 37549059578     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2007.00769.x     Document Type: Article

References (16)

1. Ostor AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993 12 : 186 92.
2. Baak JP, Kruse AJ, Robboy SJ, Janssen EA, van Diermen B, Skaland I. Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers. J Clin Pathol 2006 59 : 1017 28.
3. Sadler L, Saftlas A, Wang W, Exeter M, Whittaker J, McCowan L. Treatment for cervical intraepithelial neoplasia and risk of preterm delivery. JAMA 2004 291 : 2100 6.
4. Kyrgiou M, Koliopoulos G, Martin-Hirsch P, Arbyn M, Prendiville W, Paraskevaidis E. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet 2006 367 : 489 98.
5. Sjoeborg KD, Hole S, Tanbo S. Pregnancy outcome after cervical cone excision: a case-control study. Acta Obstet Gynecol Scand 2007 86 : 423 8.
6. Lorincz AT, Castle PE, Sherman ME. Viral load of human papillomavirus and risk of CIN3 or cervical cancer. Lancet 2002 360 : 228 9.
7. Ylitalo N, Sorensen P, Josefsson AM, Magnusson PK, Andersen PK, Ponten J, et al. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet 2000 355 : 2194 8.
8. Baak JP, Kruse AJ, Garland SM, Skaland I, Janssen EA, Tabrizi S, et al. Combined p53 and retinoblastoma protein detection identifies persistent and regressive cervical high-grade squamous intraepithelial lesions. Am J Surg Pathol 2005 29 : 1062 6.
9. Kruse AJ, Baak JP, Janssen EA, Bol MG, Kjellevold KH, Fiane B, et al. Low- and high risk CIN1 and 2 lesions: prospective predictive value of grade, HPV and Ki-67 immuno-quantitative variables. J Pathol 2003 199 : 462 70.
10. Kruse AJ, Baak JP, de Bruin PC, Jiwa M, Snijders WP, Boodt PJ, et al. Ki-67 immunoquantitation in cervical intraepithelial neoplasia (CIN): a sensitive marker for grading. J Pathol 2001 193 : 48 54.
11. Trimble CL, Piantadosi S, Gravitt P, Ronnett B, Pizer E, Elko A, et al. Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype. Clin Cancer Res 2005 11 : 4717 23.
12. Crum CP. The beginning of the end for cervical cancer? N Engl J Med 2002 347 : 1703 5.
13. Schiffman M, Solomon D. Findings to date from the ASCUS-LSIL Triage Study (ALTS). Arch Pathol Lab Med 2003 127 : 946 9.
14. Sun CA, Lai HC, Chang CC, Neih S, Yu CP, Chu TY. The significance of human papillomavirus viral load in prediction of histologic severity and size of squamous intraepithelial lesions of uterine cervix. Gynecol Oncol 2001 83 : 95 9.
15. Crum CP, Abbott DW, Quade BJ. Cervical cancer screening: from the papanicolaou smear to the vaccine era. J Clin Oncol 2003 21 : 224 30.
16. Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002 347 : 1645 51.